Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05775016 · ClinicalTrials.gov registry record · NA
Effects of Adding L-BAIBA to Exercising Adult Overweight and Obese Men and Women
A NA study, sponsored by Lindenwood University.
- Terminated
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT05775016 is a NA study that was terminated before completion, run by Lindenwood University. The registered enrollment target is 23 participants.
The verdict
NCT05775016, a NA study, was terminated before completion, sponsored by Lindenwood University.
- TERMINATED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
Beta-amino isobutyric acid (BAIBA) is a myokine produced in skeletal muscle and has been shown to impact how our body metabolizes fuel. We seek to examine changes in body composition, weight loss, glucose control, and cardiometabolic risk factors after adding supplementation of BAIBA to exercise in overweight and obese men and women.
Interventions
- BEHAVIORAL Exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2023-03-29 |
| Est. Completion | 2024-04-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05775016
The ClinicalTrials.gov registry entry for NCT05775016 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lindenwood University, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Exercise is the first listed.
NCT05775016 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05775016 about?
NCT05775016 is a clinical study titled "Effects of Adding L-BAIBA to Exercising Adult Overweight and Obese Men and Women". Beta-amino isobutyric acid (BAIBA) is a myokine produced in skeletal muscle and has been shown to impact how our body metabolizes fuel. We seek to examine changes in body composition, weight loss, glucose control, and cardiometabolic risk factors after adding supplementation of BAIBA to exercise in ...
What is the current status of trial NCT05775016?
This trial is currently terminated. It is a NA study. The enrollment target is 23 participants. The study started on 2023-03-29. Estimated completion is 2024-04-23.
What interventions are being tested in trial NCT05775016?
The interventions under investigation include: Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT05775016?
This trial is sponsored by Lindenwood University, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.